Thermo Fisher Scientific (TMO) Tops Q3 Earnings and Revenue Estimates
Thermo Fisher Scientific (TMO) Tops Q3 Earnings and Revenue Estimates Yahoo Finance Singapore
Covered in this story
Analyst targets on Thermo Fisher Scientific
- Morgan Stanley: $663 → $730 by Oct 2027 · Overweight via ad-hoc-news.de
- UBS: $606 → $730 by Sep 2027 · Buy via Investing.com
- Morgan Stanley: $560 → $650 by Jul 2027 · Overweight via GuruFocus
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $TMO yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Thermo Fisher Scientific →Also covered by 3 other outlets
- Q3 2026 Thermo Fisher Scientific Inc Earnings Call Transcript
- Thermo Fisher Scientific Q3 2026 Earnings Call Transcript
- Thermo Fisher Scientific Inc (TMO) (Q3 2026) Earnings Call Highlights: Revenue Up 9% to $12. ...
Dalsna Finance is currently tracking 45 stories mentioning Thermo Fisher Scientific, the earliest published 9 Jul 2026.
Summary aggregated from Yahoo Finance Singapore's public RSS feed. The full reporting belongs to Yahoo Finance Singapore — please read it on their site.